Ksenia Bezverbnaya

发表

A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell Toxicity

B. Nelson, G. Denisova, K. Milne, 2020, Molecular therapy oncolytics.

The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity

B. Nelson, G. Denisova, K. Milne, 2018, Nature Communications.

Involvement of the HCK and FGR src-Family Kinases in FCRL4-Mediated Immune Regulation

B. Treanor, G. R. Ehrhardt, Yanling Liu, 2015, The Journal of Immunology.

Immune Regulation src-Family Kinases in FCRL4-Mediated Involvement of the HCK and FGR

B. Treanor, Ehrhardt, Yanling Liu, 2015 .

TGFβ Programs Central Memory Differentiation in Ex Vivo–Stimulated Human T Cells

J. Bramson, Manon Richaud, J. Delisle, 2019, Cancer Immunology Research.

Tumor-targeting domains for chimeric antigen receptor T cells.

J. Bramson, C. Helsen, Jesse Sidhu, 2017, Immunotherapy.

Metformin-induced reductions in tumor growth involves modulation of the gut microbiome

Amogelang R. Raphenya, P. Muti, G. Blandino, 2022, Molecular metabolism.

T-cell engineered with a fully humanized B-cell maturation antigen-specific T-cell antigen coupler receptor effectively target multiple myeloma.

Bella Groisman, A. Bader, J. Bramson, 2023, Cytotherapy.

Development of a B-cell maturation antigen-specific T-cell antigen coupler receptor for multiple myeloma.

G. Denisova, J. Bramson, Jamie D McNicol, 2021, Cytotherapy.

Evaluation of Lymphadenopathy and Suspected Lymphoma in a Lymphoma Rapid Diagnosis Clinic.

R. Kridel, J. Delabie, M. Maganti, 2019, Journal of oncology practice.